A 17-year analysis found sex-based differences in the prevalence and treatment of patients with ST-segment elevation MI with nonobstructive coronary arteries, but the mortality risk remains similar.

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study was aimed at exploring immune-related genes and their expression changes in myocardial ...

The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term ...

Data suggest a dose-related association between progestin-only products and arterial thrombotic risk. Various hormonal contraceptives were linked to incident cardiovascular disease in an analysis of ...

Higher dietary cholesterol intake is linked to an increased risk of myocardial infarction among U.S. veterans, reinforcing ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

For patients with acute myocardial infarction (MI) and anemia, 30-day mortality and MI did not differ between restrictive ...

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted ...

Unrecognized or silent myocardial infarction (MI) detected on an ECG is associated with first‐ever stroke, but the impact on stroke recurrence is unknown. We aimed to determine the association of ...